GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,190 Cr | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr |
What is the latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹4,190 Cr |
| Mar2025 | ₹3,967 Cr |
| Mar2024 | ₹3,410 Cr |
| Mar2023 | ₹3,193 Cr |
| Mar2022 | ₹4,520 Cr |
How is Total Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,190 Cr | 5.62 | |
| Mar2025 | ₹3,967 Cr | 16.33 | |
| Mar2024 | ₹3,410 Cr | 6.80 | |
| Mar2023 | ₹3,193 Cr | -29.36 | |
| Mar2022 | ₹4,520 Cr | - | |
Compare Total Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,588.5 Cr | 1.6% | 11.7% | -22.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.6% |
11.7% |
-22.9% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses